AF
EXEL icon

Amalgamated Financial’s Exelixis EXEL Stock Holding History

Amalgamated Financial’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5.27M Buy
+232,559
New +$4.54M 0.04% 440

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Amalgamated Financial's EXEL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Exelixis (EXEL) in Q1 2022: 232,559 shares worth $5.27M. The stake represents 0.04% of the portfolio and ranks #440 among its holdings.

364 funds tracked by Wall St. Rank hold EXEL as of Q1 2022.

  • Amalgamated Financial held 232,559 shares of Exelixis worth $5.27M as of Q1 2022.
  • Exelixis was a new Amalgamated Financial position in Q1 2022.
  • Exelixis made up 0.04% of Amalgamated Financial's portfolio in Q1 2022, its #440 holding.
  • 364 funds tracked by Wall St. Rank held Exelixis as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.